BE611502Q - Amino-alcools, leurs sels et procédé pour leur préparation - Google Patents

Amino-alcools, leurs sels et procédé pour leur préparation

Info

Publication number
BE611502Q
BE611502Q BE611502A BE611502A BE611502Q BE 611502 Q BE611502 Q BE 611502Q BE 611502 A BE611502 A BE 611502A BE 611502 A BE611502 A BE 611502A BE 611502 Q BE611502 Q BE 611502Q
Authority
BE
Belgium
Prior art keywords
salts
preparation
amino alcohols
alcohols
amino
Prior art date
Application number
BE611502A
Other languages
English (en)
French (fr)
Original Assignee
C H Boehringer Bohn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by C H Boehringer Bohn filed Critical C H Boehringer Bohn
Application granted granted Critical
Publication of BE611502Q publication Critical patent/BE611502Q/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
BE611502A 1960-02-15 1961-12-13 Amino-alcools, leurs sels et procédé pour leur préparation BE611502Q (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEB56662A DE1275069B (de) 1960-02-15 1960-02-15 1-(3', 5'-Dihydroxyphenyl)-1-hydroxy-2-isopropylaminoalkane und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
BE611502Q true BE611502Q (fr) 1962-03-30

Family

ID=6971416

Family Applications (1)

Application Number Title Priority Date Filing Date
BE611502A BE611502Q (fr) 1960-02-15 1961-12-13 Amino-alcools, leurs sels et procédé pour leur préparation

Country Status (9)

Country Link
US (2) US3341594A (OSRAM)
BE (1) BE611502Q (OSRAM)
CH (3) CH413863A (OSRAM)
DE (1) DE1275069B (OSRAM)
FR (2) FR1466215A (OSRAM)
GB (1) GB920623A (OSRAM)
NL (1) NL120608C (OSRAM)
OA (1) OA01090A (OSRAM)
SE (2) SE220245C1 (OSRAM)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023203223A1 (en) 2022-04-22 2023-10-26 Atrogi Ab Combinations of beta 2-adrenergic receptor agonists and beta 3-adrenergic receptor agonists, and medical uses thereof
WO2024153813A1 (en) 2023-01-20 2024-07-25 Atrogi Ab Beta 2-adrenergic receptor agonists for treatment or prevention of muscle wasting
WO2024170727A1 (en) 2023-02-16 2024-08-22 Atrogi Ab Combinations of beta 2-adrenergic receptor agonists and metformin for use in treating obesity and reducing body fat
WO2024184408A1 (en) 2023-03-06 2024-09-12 Atrogi Ab Combination of beta-2-adrenergic receptor agonists and glp-1 receptor agonists for use in treating hyperglycaemia
WO2025186320A1 (en) 2024-03-05 2025-09-12 Atrogi Ab Combinations of beta 2-adrenergic receptor agonists and sglt2 inhibitors for use in treating hyperglycaemia or a disorder characterized by hyperglycaemia
WO2025238248A1 (en) 2024-05-17 2025-11-20 Atrogi Ab USE OF β2-ADRENERGIC RECEPTOR AGONISTS IN TREATING MUSCLE WASTING

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670342A1 (de) * 1966-04-23 1970-10-29 Albert Ag Chem Werke Verfahren zur Herstellung eines neuen nikotinsauren Salzes
US3937838A (en) * 1966-10-19 1976-02-10 Aktiebolaget Draco Orally active bronchospasmolytic compounds and their preparation
US4138581A (en) * 1969-04-01 1979-02-06 Sterling Drugs Inc. 3(Hydroxy or hydroxymethyl)-4(hydroxy)-α-(aminomethyl)benzyl alcohols
US4336400A (en) * 1969-04-01 1982-06-22 Sterling Drug Inc. 3-(Hydroxy or hydroxymethyl)-4-hydroxy-alpha(aminomethyl)benzyl alcohols and methods of use
US4335124A (en) * 1973-08-20 1982-06-15 Sandoz, Inc. 1-Alkyl, 1-phenyl-butenes
AR207639A1 (es) * 1973-12-26 1976-10-22 Pfizer Un procedimiento para preparar pirido (3,2-d)1,3-dioxin-6-epoxietanos y compuestos intermediarios desprovistos de actividad terapeutica
US4017632A (en) * 1975-10-22 1977-04-12 Centre European De Recherches Pharmacologiques C.E.R.P.H.A. Phenoxyacetic acid derivatives
EP0043807B1 (en) 1980-07-09 1984-05-30 Aktiebolaget Draco 1-(dihydroxyphenyl)-2-amino-ethanol derivatives; preparation, compositions and intermediates
EP0103830A3 (de) * 1982-09-22 1985-07-31 Bayer Ag Wachstumsfördernde Phenylethylamin-Derivate
US4479967A (en) * 1982-09-30 1984-10-30 Ciba-Geigy Corporation Method of lowering intraocular pressure with ibuterol
US4525359A (en) * 1982-12-10 1985-06-25 Greenway Frank L Iii Treatment for selective weight control
US5464387A (en) * 1991-07-24 1995-11-07 Alza Corporation Transdermal delivery device
MX2007012084A (es) 2005-03-30 2007-11-21 Schering Corp Medicamentos y metodos que combinan un anticolinergico, un corticosteroide y un agonista beta de accion prolongada.
BR112015011897B1 (pt) 2012-12-03 2021-11-03 Pfizer Inc Compostos moduladores seletivos do receptor de andrógeno e seu uso
WO2014108449A1 (en) 2013-01-08 2014-07-17 Atrogi Ab A screening method, a kit, a method of treatment and a compound for use in a method of treatment
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201903832D0 (en) 2019-03-20 2019-05-01 Atrogi Ab New compounds and methods

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE865315C (de) * 1943-07-27 1953-02-02 Albert Ag Chem Werke Verfahren zur Herstellung von 3, 5-Dioxyphenylaethanolaminen
US2725399A (en) * 1949-11-03 1955-11-29 American Cyanamid Co Tertiary dialkylamino propanols
US2765307A (en) * 1953-02-11 1956-10-02 Rohm & Haas Hydroxyamines
US2766286A (en) * 1953-07-15 1956-10-09 Lepetit Spa Process for the resolution of racemic threo-1-phenyl-2-amino-1. 3-propanediol
US2937118A (en) * 1956-06-27 1960-05-17 Raschig Gmbh Dr F Aminopyridine compositions
US2820739A (en) * 1956-09-05 1958-01-21 Merck & Co Inc Antitussive compositions
US3048633A (en) * 1960-12-02 1962-08-07 American Home Prod N-lower alkyl-2-(benzyloxatedphenyl)-glycolamide

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023203223A1 (en) 2022-04-22 2023-10-26 Atrogi Ab Combinations of beta 2-adrenergic receptor agonists and beta 3-adrenergic receptor agonists, and medical uses thereof
WO2024153813A1 (en) 2023-01-20 2024-07-25 Atrogi Ab Beta 2-adrenergic receptor agonists for treatment or prevention of muscle wasting
WO2024170727A1 (en) 2023-02-16 2024-08-22 Atrogi Ab Combinations of beta 2-adrenergic receptor agonists and metformin for use in treating obesity and reducing body fat
WO2024184408A1 (en) 2023-03-06 2024-09-12 Atrogi Ab Combination of beta-2-adrenergic receptor agonists and glp-1 receptor agonists for use in treating hyperglycaemia
WO2025186320A1 (en) 2024-03-05 2025-09-12 Atrogi Ab Combinations of beta 2-adrenergic receptor agonists and sglt2 inhibitors for use in treating hyperglycaemia or a disorder characterized by hyperglycaemia
WO2025238248A1 (en) 2024-05-17 2025-11-20 Atrogi Ab USE OF β2-ADRENERGIC RECEPTOR AGONISTS IN TREATING MUSCLE WASTING

Also Published As

Publication number Publication date
DE1275069B (de) 1968-08-14
FR1466215A (fr) 1967-01-20
CH410009A (de) 1966-03-31
SE220245C1 (sv) 1968-04-30
OA01090A (fr) 1968-08-07
US3341594A (en) 1967-09-12
CH413863A (de) 1966-05-31
NL120608C (nl) 1966-02-15
GB920623A (en) 1963-03-13
US3422196A (en) 1969-01-14
FR922M (OSRAM) 1961-10-20
SE310889B (sv) 1969-05-19
NL261247A (nl) 1964-05-11
CH410008A (de) 1966-03-31

Similar Documents

Publication Publication Date Title
BE611502Q (fr) Amino-alcools, leurs sels et procédé pour leur préparation
FR1309832A (fr) Procédé de préparation de dinitropyrroles substitués en position 1.
BE604584A (fr) Procédé pour la préparation de nouvelles 3-phényl-pyrrolidines et de leurs sels.
BE588740A (fr) Procédé de préparation de nouveaux aza-composés, notamment de tertio(inférieur)-amino-alcoyl (inférieur)-7-aza-benzimidazoles et de leurs sels.
FR1466205A (fr) Acide 1-cétocyclododécyl-2-acétique, ses sels et leur procédé de préparation
FR1267507A (fr) Procédé de préparation de 3-alcoyloxyaldéhydes
FR1301282A (fr) Procédé pour la préparation de nouvelles 3-phényl-pyrrolidines et de leurs sels
BE598792A (fr) Procédé de préparation de nouvelles hydrazines, notamment de 2-hydrazino-indanes et de leurs sels
CH456158A (fr) Procédé de préparation de nouveaux sels
BE598793A (fr) Procédé de préparation de nouvelles hydrazines, notamment de 2-hydrazino-1,2,3,4,-tétrahydro-naphtalènes, et de leurs sels
OA01036A (fr) Procédé de préparation de pénicillines et de leurs sels non toxiques.
FR1288025A (fr) Procédé de préparation de nouvelles piperidones-(4) substituées en position 1, 2, 6 ou de leurs sels
FR1253220A (fr) Procédé de préparation de 4-alcoxymétanilamides et de leurs sels
FR1274149A (fr) Procédé de préparation de nitroacétals
FR1306621A (fr) Procédé de préparation de 2-aminooxazoles
BE594837R (fr) Procédé de préparation de nouveaux benzothiazols et de leurs sels.
FR1275197A (fr) Procédé de préparation des stéroïdes-21-orthophosphates et de leurs sels
BE606379A (fr) Procédé de préparation de sels de nitro-cyano-guanidine.
BE610389A (fr) Procédé pour la préparation de la gamma-morpholino-butyrophénone et de ses sels.
FR239M (fr) Sels de quinaldinium et leur procédé de préparation.
FR1331942A (fr) Procédé de préparation de nouvelles guanidines, notamment de 2-(nu-cyclohexyl-amino)-alcoyl-guanidines et de leurs sels
BE609561A (fr) Procédé de préparation de l'hydrochlorure de 5-bis-/beta - chloréthyle/-aminométhyle-uracil
FR1437355A (fr) Procédé de préparation de nouveaux benzylcycloalkanoléthers, de leurs sels et de leurs combinaisons ammonium quaternaire
FR1300719A (fr) Procédé de préparation de o-monophosphate de benzoylthiamine et ses sels
FR1246164A (fr) Procédé de préparation de nouvelles 2-imino-thiazolidine-4-ones et de leurs sels